Target Name: MIR4680
NCBI ID: G100616113
Review Report on MIR4680 Target / Biomarker Content of Review Report on MIR4680 Target / Biomarker
MIR4680
Other Name(s): MicroRNA 4680 | microRNA 4680 | hsa-miR-4680-5p | hsa-mir-4680 | hsa-miR-4680-3p

MIR4680: A Potential Drug Target and Biomarker

Mir4680, also known as interleukin-4680, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. Its unique structure and function have made it an attractive target for researchers to investigate, and recent studies have shed light on its potential implications as a drug.

MIR4680 is a small non-coding RNA molecule that is expressed in various tissues and cells, including the brain, pancreas, and testes. It is a part of the MIR4680 gene family, which is characterized by the presence of a conserved core region and a unique N-terminus region that is known as the exonic region. The exonic region is responsible for the translation of the RNA molecule into a functional protein.

One of the most significant features of MIR4680 is its unique structure. It has a characteristic stem-loop structure that is composed of a series of alternating double-stranded regions and a single-stranded region at the end. This unique structure has been observed in various RNA molecules, including MIR4680, and is thought to play a significant role in its function.

MIR4680 has also been shown to have various functions in various organisms. For example, studies have shown that MIR4680 is involved in the regulation of gene expression, specifically in the regulation of immune responses and inflammation. It has also been shown to play a role in the development and progression of various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

One of the most promising aspects of MIR4680 is its potential as a drug target. Its unique structure and function have made it an attractive target for researchers to investigate, and recent studies have shed light on its potential implications as a drug. For example, studies have shown that MIR4680 can be targeted with small molecules, antibodies, and other therapeutic agents, which could lead to new treatments for various diseases.

In addition to its potential as a drug target, MIR4680 has also been shown to be a potential biomarker for various diseases. Its unique structure and function make it an attractive target for diagnostic tools, such as qRT-PCR, western blotting, and mass spectrometry. Studies have shown that these diagnostic tools can be used to detect MIR4680 in various tissues and cells, which could be used as biomarkers for various diseases.

MIR4680 has also been shown to have a role in the regulation of cellular processes, including cell growth, apoptosis, and inflammation. Its functions in these processes have led to its potential as a drug target for various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

In conclusion, MIR4680 is a unique and promising molecule that has the potential to be a drug target and biomarker for various diseases. Its characteristic structure and function, as well as its potential as a regulator of cellular processes, make it an attractive target for researchers to investigate. Further studies are needed to fully understand its potential as a drug and to determine its utility as a biomarker for various diseases.

Protein Name: MicroRNA 4680

The "MIR4680 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4680 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785